Lupin’s shares rose 2.8% in afternoon trading after the company received a key U.S. Food and Drug Administration (FDA) ...

Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension ...

Lupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA ...

Risperidone Injectable is the bioequivalent to the reference listed drug (RLD), Risperdal Consta Long-Acting Injection. It is ...

Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing ...